Exogenous CX3CL1 reduced ischemia-induced cerebral infarct size and neurological deficits in rats and these CX3CL1-induced neuroprotective effects mediated by microglia were long lasting, being observed up to 50 days after pMCAO in rats [23]. Here, CX3CL1 is linked to brain infarction.